{
  "meta": {
    "title": "24_Glaucoma",
    "url": "https://brainandscalpel.vercel.app/24-glaucoma-9de5a058.html",
    "scrapedAt": "2025-11-30T06:59:47.565Z"
  },
  "questions": [
    {
      "id": 95969,
      "choices": [
        {
          "id": 206325,
          "text": "Prodrug of adrenaline"
        },
        {
          "id": 206326,
          "text": "Decreases hydraulic conductivity of trabecular filtering cells"
        },
        {
          "id": 206327,
          "text": "Lowers intraocular tension by augmentation of uveoscleral outflow"
        },
        {
          "id": 206328,
          "text": "Reduces aqueous humor formation"
        }
      ],
      "text": "The following are true about Dipivefrine except",
      "unique_key": "Q3728339",
      "question_audio": null,
      "question_video": null,
      "map_id": 34217953,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Decreases hydraulic conductivity of trabecular filtering cells. Dipivefrine does not decrease the hydraulic conductivity of trabecular filtering cells; instead, it enhances aqueous humor outflow. Dipivefrine is a prodrug of adrenaline (epinephrine) that is used in the treatment of open-angle glaucoma to lower intraocular pressure (IOP). It is converted to epinephrine in the eye, where it exerts its effects by enhancing aqueous humor outflow via both the trabecular and uveoscleral pathways and reducing aqueous humor production. Since it does not obstruct or decrease hydraulic conductivity of trabecular filtering cells, option (B) is incorrect. Incorrect Options (True Statements): (A) Prodrug of adrenaline: This statement is correct. Dipivefrine is an ester prodrug of adrenaline (epinephrine), meaning it is metabolized into its active form within the eye. This enhances corneal penetration, prolongs action, and reduces systemic side effects compared to direct adrenaline administration. (C) Lowers intraocular tension by augmentation of uveoscleral outflow: This is correct. Dipivefrine enhances aqueous humor drainage through the uveoscleral outflow pathway, thereby reducing intraocular pressure (IOP). This mechanism helps in the management of glaucoma by facilitating better aqueous humor clearance. (D) Reduces aqueous humor formation: This is correct. Dipivefrine decreases aqueous humor production by causing vasoconstriction of ciliary body blood vessels. Reduced blood flow to the ciliary body leads to less aqueous humor secretion, which helps lower intraocular pressure in glaucoma patients.",
      "correct_choice_id": 206326,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7923011700118252/7923011700118252.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7923011700118252/7923011700118252.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95970,
      "choices": [
        {
          "id": 206329,
          "text": "Latanosprost"
        },
        {
          "id": 206330,
          "text": "Betaxolol"
        },
        {
          "id": 206331,
          "text": "Apraclonidine"
        },
        {
          "id": 206332,
          "text": "Dorzolamide"
        }
      ],
      "text": "Which of the following anti-glaucoma drug cause bitter taste on topical application in eyes",
      "unique_key": "Q2785402",
      "question_audio": null,
      "question_video": null,
      "map_id": 34860726,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Dorzolamide. Dorzolamide is a topical carbonic anhydrase inhibitor (CAI) used in the treatment of glaucoma to lower intraocular pressure (IOP) by reducing aqueous humor production. One of its notable side effects is a bitter taste after topical application. This occurs because dorzolamide drains into the nasolacrimal duct, leading to systemic absorption and stimulation of taste receptors in the oropharynx. This bitter taste sensation is a well-documented adverse effect of carbonic anhydrase inhibitors like dorzolamide and brinzolamide. Incorrect Options (True Statements): (A) Latanoprost: This is incorrect. Latanoprost is a prostaglandin analog used to increase uveoscleral outflow and lower intraocular pressure. It is generally well-tolerated but is associated with side effects such as iris pigmentation, eyelash growth, and conjunctival hyperemia. However, it does not commonly cause a bitter taste. (B) Betaxolol: This is incorrect. Betaxolol is a selective beta-1 adrenergic blocker that reduces intraocular pressure by decreasing aqueous humor production. While some beta-blockers like timolol may have systemic side effects, betaxolol does not cause a significant bitter taste after topical application. (C) Apraclonidine: This is incorrect. Apraclonidine is an alpha-2 adrenergic agonist that works by reducing aqueous humor production and increasing uveoscleral outflow. Its side effects include ocular allergy, dry mouth, and conjunctival blanching, but it is not commonly associated with a bitter taste.",
      "correct_choice_id": 206332,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7361321700118983/7361321700118983.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7361321700118983/7361321700118983.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95971,
      "choices": [
        {
          "id": 206333,
          "text": "Timolol"
        },
        {
          "id": 206334,
          "text": "Levobunolol"
        },
        {
          "id": 206335,
          "text": "Betaxolol"
        },
        {
          "id": 206336,
          "text": "None"
        }
      ],
      "text": "Which of the following has more retinoprotective effects",
      "unique_key": "Q9043687",
      "question_audio": null,
      "question_video": null,
      "map_id": 34346713,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Betaxolol. Betaxolol is a selective beta-1 adrenergic blocker that reduces intraocular pressure (IOP) by decreasing aqueous humor production in the ciliary body. Unlike non-selective beta-blockers, betaxolol has neuroprotective properties due to its ability to improve ocular blood flow and prevent apoptosis of retinal ganglion cells. This retinoprotective effect makes betaxolol particularly beneficial in glaucoma management, as it helps preserve retinal function beyond just reducing IOP. Incorrect Options (True Statements): (A) Timolol: This is incorrect. Timolol is a non-selective beta-blocker that effectively reduces intraocular pressure by inhibiting aqueous humor production. However, unlike betaxolol, timolol does not have significant neuroprotective effects. Additionally, as a non-selective beta-blocker, it can cause systemic side effects, including bronchospasm and bradycardia, which are less likely with betaxolol. (B) Levobunolol: This is incorrect. Levobunolol is another non-selective beta-blocker, similar to timolol, and reduces IOP by decreasing aqueous humor production. However, it lacks the retinoprotective and neuroprotective effects seen with betaxolol. (D) None: This is incorrect. Since betaxolol has proven retinoprotective effects, selecting \"None\" would be an incorrect choice.",
      "correct_choice_id": 206335,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54121451700119025/54121451700119025.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54121451700119025/54121451700119025.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95972,
      "choices": [
        {
          "id": 206337,
          "text": "Latanoprost"
        },
        {
          "id": 206338,
          "text": "Dipivefrine"
        },
        {
          "id": 206339,
          "text": "Trovaprost"
        },
        {
          "id": 206340,
          "text": "Betaxolol"
        }
      ],
      "text": "Which of the following acts by decreasing aqueous humor",
      "unique_key": "Q6102669",
      "question_audio": null,
      "question_video": null,
      "map_id": 34445007,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Betaxolol. Betaxolol is a selective beta-1 adrenergic blocker that lowers intraocular pressure (IOP) by decreasing the production of aqueous humor in the ciliary body. By blocking beta-1 receptors, betaxolol reduces the secretion of aqueous humor, thereby decreasing intraocular pressure. Additionally, it has retinoprotective properties, making it a preferred option for patients with glaucoma, especially those at risk of optic nerve damage. Incorrect Options (True Statements): (A) Latanoprost: Incorrect. Latanoprost is a prostaglandin analog that primarily works by increasing the outflow of aqueous humor via the uveoscleral pathway rather than decreasing its production. It does not act by reducing aqueous humor formation. (B) Dipivefrine: Incorrect. Dipivefrine is a prodrug of epinephrine that acts as a non-selective adrenergic agonist. It primarily lowers IOP by enhancing aqueous humor outflow rather than reducing its production. It does have some minor effect on aqueous humor formation but is not the primary mechanism. (C) Travoprost: Incorrect. Travoprost is another prostaglandin analog, similar to latanoprost, that works by increasing uveoscleral outflow of aqueous humor. It does not significantly decrease aqueous humor production.",
      "correct_choice_id": 206340,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71274961700119060/71274961700119060.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71274961700119060/71274961700119060.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95973,
      "choices": [
        {
          "id": 206341,
          "text": "Dipivefrine"
        },
        {
          "id": 206342,
          "text": "Timolol"
        },
        {
          "id": 206343,
          "text": "physostigmine"
        },
        {
          "id": 206344,
          "text": "Bimatoprost"
        }
      ],
      "text": "Growth of eyelashes is caused by",
      "unique_key": "Q7439647",
      "question_audio": null,
      "question_video": null,
      "map_id": 34276001,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Bimatoprost. Bimatoprost is a prostaglandin analog that primarily works by increasing the outflow of aqueous humor via the uveoscleral pathway, thereby lowering intraocular pressure in patients with glaucoma. However, one of its well-known side effects is the enhancement of eyelash growth (hypertrichosis). This effect has been utilized in cosmetic medicine under the brand name Latisse, which is FDA-approved for increasing eyelash length, thickness, and darkness. Incorrect Options (True Statements): (A) Dipivefrine: Incorrect. Dipivefrine is a prodrug of epinephrine that reduces intraocular pressure by increasing aqueous humor outflow. However, it does not stimulate eyelash growth as its mechanism does not involve prostaglandin receptor activation. (B) Timolol: Incorrect. Timolol is a non-selective beta-blocker that reduces intraocular pressure by decreasing aqueous humor production. It does not promote eyelash growth, as beta-blockers have no effect on hair follicle stimulation. (C) Physostigmine: Incorrect. Physostigmine is a cholinesterase inhibitor that increases aqueous humor outflow by contracting the ciliary muscle and opening the trabecular meshwork. It does not stimulate eyelash growth, as its mechanism of action does not involve prostaglandins or hair follicle stimulation.",
      "correct_choice_id": 206344,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45559231700119075/45559231700119075.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45559231700119075/45559231700119075.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95974,
      "choices": [
        {
          "id": 206345,
          "text": "Is more efficacious in glaucoma"
        },
        {
          "id": 206346,
          "text": "Produces less ocular side effects"
        },
        {
          "id": 206347,
          "text": "Is shorter acting"
        },
        {
          "id": 206348,
          "text": "Is a B1 selective blocker"
        }
      ],
      "text": "The property which makes betaxolol different from timolol is that betaxolol",
      "unique_key": "Q1204763",
      "question_audio": null,
      "question_video": null,
      "map_id": 34189826,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Betaxolol is a β1-selective blocker. Betaxolol is a cardioselective β1-blocker, whereas timolol is a non-selective β-blocker (blocks both β1 and β2 receptors). This selectivity is important because β2 receptors are present in the bronchial smooth muscle and ciliary body. By selectively blocking β1 receptors, betaxolol has a lower risk of causing bronchospasm, making it a safer option for glaucoma patients with respiratory conditions like asthma or COPD. Incorrect Options (True Statements): (A) Betaxolol is more efficacious in glaucoma – Incorrect. Both betaxolol and timolol effectively lower intraocular pressure, but timolol is generally considered more potent due to its non-selective β-blockade, which inhibits aqueous humor production more strongly. Betaxolol, while effective, has a slightly weaker intraocular pressure-lowering effect than timolol. (B) Betaxolol produces less ocular side effects – Incorrect. Betaxolol does have fewer systemic side effects, particularly regarding respiratory complications, because it lacks β1 blockade. However, in terms of ocular side effects like stinging or discomfort, betaxolol can actually cause more irritation than timolol due to its slightly higher acidity. (C) Betaxolol is shorter-acting – Incorrect. Betaxolol has a longer duration of action compared to timolol and is often dosed once daily, whereas timolol typically requires twice-daily dosing. This makes betaxolol more convenient for patients who prefer a once-daily regimen.",
      "correct_choice_id": 206348,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65891591700119553/65891591700119553.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65891591700119553/65891591700119553.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95975,
      "choices": [
        {
          "id": 206349,
          "text": "Timolol"
        },
        {
          "id": 206350,
          "text": "Carteolol"
        },
        {
          "id": 206351,
          "text": "Metoprolol"
        },
        {
          "id": 206352,
          "text": "Betaxolol"
        }
      ],
      "text": "Which of the following is the longest acting ocular beta blocker?",
      "unique_key": "Q4313840",
      "question_audio": null,
      "question_video": null,
      "map_id": 34604889,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Betaxolol, as it is the longest-acting ocular beta-blocker. Betaxolol is a cardioselective (??-selective) blocker that reduces intraocular pressure by decreasing aqueous humor production. It has a longer duration of action compared to other beta-blockers, allowing for once-daily dosing in many patients. This prolonged effect is due to its higher lipophilicity, which enables sustained penetration into ocular tissues and prolonged receptor binding. Incorrect Options (Shorter-acting Beta Blockers): (A) Timolol – Incorrect. Timolol is a non-selective Beta-blocker commonly used for glaucoma. While it is effective in lowering intraocular pressure, it has a shorter duration of action than betaxolol, typically requiring twice-daily dosing. Unlike betaxolol, timolol can also cause more systemic side effects due to its β1-blocking properties. (B) Carteolol – Incorrect. Carteolol is another non-selective Beta-blocker with intrinsic sympathomimetic activity (ISA), meaning it has partial agonist activity at beta receptors. While it has a moderate duration of action, it is still shorter than betaxolol and usually requires twice-daily dosing. (C) Metoprolol – Incorrect. Metoprolol is a β1-selective blocker, but it is not commonly used as an ocular agent. It is primarily used for systemic conditions like hypertension and heart disease. Since it is not formulated for ophthalmic use, it does not have a relevant duration of action in the eye.",
      "correct_choice_id": 206352,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43736451700120185/43736451700120185.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43736451700120185/43736451700120185.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95976,
      "choices": [
        {
          "id": 206353,
          "text": "B1 receptor"
        },
        {
          "id": 206354,
          "text": "A2 receptor"
        },
        {
          "id": 206355,
          "text": "B2 receptor"
        },
        {
          "id": 206356,
          "text": "M2 receptor"
        }
      ],
      "text": "Agonistic action at which of the following adrenergic receptors results in the reduction of aqueous secretion?",
      "unique_key": "Q3190150",
      "question_audio": null,
      "question_video": null,
      "map_id": 34521228,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) A2 receptor. Agonistic action at A2-adrenergic receptors results in a reduction of aqueous humor secretion, leading to decreased intraocular pressure. A2-receptors are located on the ciliary body epithelium and sympathetic nerve terminals, where their activation inhibits norepinephrine release, reducing A-receptor-mediated stimulation of aqueous humor production. This mechanism is utilized by alpha-2 agonists like brimonidine and apraclonidine, which are used in glaucoma treatment to lower intraocular pressure. Incorrect Options: (A) B1 receptor – Incorrect. β1-adrenergic receptors stimulate aqueous humor production by increasing cyclic AMP (cAMP) levels in the ciliary epithelium. Activation of ?? receptors leads to increased aqueous humor secretion, which would worsen glaucoma rather than help treat it. This is why ??-blockers like betaxolol are used in glaucoma therapy to reduce aqueous humor production. (C) B2 receptor – Incorrect. β2 receptors are also present in the ciliary body and have a similar effect as β2 receptors. Activation of β2 receptors increases aqueous humor production, which is counterproductive in glaucoma treatment. Blocking β2 receptors with non-selective β-blockers like timolol helps lower intraocular pressure. (D) M2 receptor – Incorrect. M2 receptors are muscarinic cholinergic receptors, primarily found in cardiac and smooth muscle. While muscarinic agonists (like pilocarpine) can reduce intraocular pressure, this occurs by enhancing trabecular outflow rather than decreasing aqueous humor production. M2 receptors do not play a significant direct role in reducing aqueous secretion.",
      "correct_choice_id": 206354,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41316431700120218/41316431700120218.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41316431700120218/41316431700120218.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95977,
      "choices": [
        {
          "id": 206357,
          "text": "Timolol"
        },
        {
          "id": 206358,
          "text": "Brimonidine"
        },
        {
          "id": 206359,
          "text": "Bimatoprost"
        },
        {
          "id": 206360,
          "text": "Brinzolamide"
        }
      ],
      "text": "A patient, known case of open angle glaucoma, using some anti glaucoma drug since 1year. Now patient has visited to your clinic with problems shown in image. Which drug is responsible for this?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/4(134).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9945381",
      "question_audio": null,
      "question_video": null,
      "map_id": 34085917,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Bimatoprost. The patient in this scenario is presenting with periorbital darkening, eyelash growth, and thickening of the eyelashes. These are known side effects associated with prostaglandin analogs like bimatoprost, which is commonly used to treat open-angle glaucoma. Bimatoprost works by increasing the outflow of aqueous humor from the eye, lowering intraocular pressure (IOP). One of the side effects of this drug is hyperpigmentation of the eyelid and increased growth of eyelashes, which is seen as darkening and elongation of eyelashes. This side effect is due to the drug's action on prostaglandin receptors in the eyelid skin and eyelash follicles. Explanation of Incorrect Options: (A) Timolol – Incorrect. Timolol is a beta-blocker used to lower intraocular pressure in glaucoma. It works by decreasing the production of aqueous humor. While it can cause side effects like dry eyes or bradycardia, it is not associated with the eyelash changes or periorbital pigmentation seen in this patient. Timolol is less likely to cause any cosmetic changes to the eyes compared to prostaglandin analogs. (B) Brimonidine – Incorrect. Brimonidine is an alpha-2 adrenergic agonist used in glaucoma treatment, which works by reducing aqueous humor production and increasing its outflow. While brimonidine may cause side effects such as dry mouth, drowsiness, or conjunctival hyperemia, it is not known to cause eyelash changes or periorbital darkening. Brimonidine typically does not have the same cosmetic side effects as prostaglandin analogs. (D) Brinzolamide – Incorrect. Brinzolamide is a carbonic anhydrase inhibitor that reduces the production of aqueous humor. Although it can cause side effects such as blurred vision, bitter taste, and ocular irritation, it does not lead to the cosmetic changes like eyelash growth or darkening of the eyelids. Like brimonidine, brinzolamide does not share the same side effect profile related to eyelash and skin pigmentation as bimatoprost.",
      "correct_choice_id": 206359,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/900671700304936/900671700304936.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/900671700304936/900671700304936.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95978,
      "choices": [
        {
          "id": 206361,
          "text": "Decreased iris pigmentation"
        },
        {
          "id": 206362,
          "text": "Diarrhea"
        },
        {
          "id": 206363,
          "text": "Hair growth of eyelashes"
        },
        {
          "id": 206364,
          "text": "Nausea"
        }
      ],
      "text": "A 48-year-old man who has been diagnosed with glaucoma visits a new ophthalmologist for second opinion who prescribes latanoprost for his glaucoma that is refractory to medical treatments. The physician must warn the patient about which of the following possible adverse effects of this medication?",
      "unique_key": "Q6985936",
      "question_audio": null,
      "question_video": null,
      "map_id": 34963899,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hair growth of eyelashes. Latanoprost is a prostaglandin F2α analog that is used in the treatment of glaucoma. It works by increasing uveoscleral outflow of aqueous humor, thereby reducing intraocular pressure (IOP). One of its well-known side effects is hypertrichosis, which refers to increased hair growth, particularly of the eyelashes (also known as eyelash hypertrichosis). This side effect has even led to the development of prostaglandin analogs like bimatoprost, which is used as an eyelash growth treatment under the brand name Latisse. Explanation of Incorrect Options: (A) Decreased iris pigmentation Incorrect because latanoprost is associated with increased iris pigmentation, not decreased. Latanoprost can cause darkening of the iris, particularly in individuals with hazel or mixed-color irises, due to an increase in melanin production. This pigmentation change is irreversible and can lead to permanent darkening of the eye color over time. (B) Diarrhea Incorrect because latanoprost is an ophthalmic medication and does not typically affect the gastrointestinal system. Unlike systemic prostaglandins, which can stimulate smooth muscle contraction in the GI tract and cause diarrhea (e.g., misoprostol), latanoprost is topically applied to the eye and has minimal systemic absorption. (D) Nausea Incorrect because latanoprost is not known to cause nausea. Prostaglandins used for other conditions (e.g., misoprostol for peptic ulcer prevention) can cause nausea as a side effect, but latanoprost is applied locally to the eye, making systemic side effects rare.",
      "correct_choice_id": 206363,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13624141700305736/13624141700305736.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13624141700305736/13624141700305736.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95979,
      "choices": [
        {
          "id": 206365,
          "text": "Lid retraction- Apraclonidine"
        },
        {
          "id": 206366,
          "text": "CNS suppression & Apnoea in neonates- Brimonidine"
        },
        {
          "id": 206367,
          "text": "Hypotrichosis of eye lashes- Latanoprost"
        },
        {
          "id": 206368,
          "text": "Black pigmentation of conjunctiva- Epinephrine"
        }
      ],
      "text": "All are true regarding side effects of anti-glaucoma drugs except:",
      "unique_key": "Q9926593",
      "question_audio": null,
      "question_video": null,
      "map_id": 34116524,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hypotrichosis of eyelashes – Latanoprost. This statement is incorrect because Latanoprost (a prostaglandin analog) actually causes eyelash growth (hypertrichosis), not hypotrichosis. Prostaglandin analogs like Latanoprost, Bimatoprost, and Travoprost are well known for enhancing the length, thickness, and darkness of eyelashes, which is why Bimatoprost is marketed for cosmetic use under the brand name Latisse. Incorrect Options: (A) Lid retraction – Apraclonidine – Correct. Apraclonidine, an Alpha2-adrenergic agonist, can cause lid retraction due to its mild Alpha 1 receptor activity, which stimulates Müller’s muscle in the eyelid. This effect leads to a wide-eyed appearance. (B) CNS suppression & Apnea in neonates – Brimonidine – Correct. Brimonidine, another Alpha 2-adrenergic agonist, has the potential to cross the blood-brain barrier, leading to CNS depression in neonates and young children. This may cause drowsiness, lethargy, and in severe cases, respiratory depression (apnea). Due to these risks, Brimonidine is contraindicated in infants. (D) Black pigmentation of conjunctiva – Epinephrine – Correct. Chronic use of epinephrine in glaucoma therapy can cause black pigmentation of the conjunctiva, along with adrenochrome deposits. This is due to oxidation of epinephrine metabolites, leading to pigmentation changes in the ocular tissues.",
      "correct_choice_id": 206367,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58648221727532672/58648221727532672.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58648221727532672/58648221727532672.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95980,
      "choices": [
        {
          "id": 206369,
          "text": "Timolol"
        },
        {
          "id": 206370,
          "text": "Pilocarpine"
        },
        {
          "id": 206371,
          "text": "Brimonidine"
        },
        {
          "id": 206372,
          "text": "Latanoprost"
        }
      ],
      "text": "A patient with glaucoma is prescribed a medication that decreases aqueous humor production. Which of the following medications is commonly used for this purpose?",
      "unique_key": "Q3752586",
      "question_audio": null,
      "question_video": null,
      "map_id": 34412315,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Timolol. Timolol is a non-selective β-blocker that effectively reduces aqueous humor production by inhibiting β2-adrenergic receptors in the ciliary body of the eye. Normally, β2 receptor activation stimulates aqueous humor formation, so blocking these receptors leads to decreased aqueous secretion, which helps lower intraocular pressure (IOP) in glaucoma patients. Due to its effectiveness, Timolol is one of the first-line agents for open-angle glaucoma. Incorrect Options: (B) Pilocarpine – Incorrect. Pilocarpine is a muscarinic (M3) cholinergic agonist that primarily increases aqueous humor outflow by contracting the ciliary muscle, which opens the trabecular meshwork and enhances drainage through the canal of Schlemm. However, it does not directly reduce aqueous humor production. It is not a first-line drug but is useful in acute angle-closure glaucoma. (C) Brimonidine – Incorrect. Brimonidine is an α2-adrenergic agonist that does reduce aqueous humor production, but it also increases uveoscleral outflow. Although it has a dual mechanism of action, it is generally used as an adjunct therapy rather than a primary agent like Timolol. (D) Latanoprost – Incorrect. Latanoprost is a prostaglandin analog that increases aqueous humor outflow via the uveoscleral pathway. It does not decrease aqueous humor production. Prostaglandin analogs are often used as first-line therapy, but they act through enhanced drainage rather than inhibition of production.",
      "correct_choice_id": 206369,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17584311727533069/17584311727533069.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17584311727533069/17584311727533069.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}